Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Learn Warren Buffett's investment strategy for beginners. Gain valuable insights from a legendary investor to guide your choices.
21,355 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A sharp weekly drain in Bitcoin ETF products highlights a split in investor demand. While BTC outflows led the pack, ...
Microsoft accelerates its AI push to reclaim leadership as market re-pricing tests margins. Nadella reshapes teams an...
As shoppers stretch budgets, investors wonder: is walmart stock still safe? This deep dive examines Walmart's defensi...
A small cadre of high-priced stocks stubbornly resist stock splits even as peers embrace them. Here are four names le...
Investors weigh if dividend income can replace a $110,000 salary through yields and risk. A blended retirement plan i...
Space is shifting from science fiction to a real investment theme. This guide breaks down how the final frontier beco...
Two real estate giants are dueling over how data is distributed. As Compass leans on MLS access to push its agenda, o...
If you rely on Social Security, the 2027 COLA forecast isn't just a number—it's a planning tool. This article breaks ...
As RMD ages move higher, retirees have a narrow window to shift high-yield dividend holdings into Roth accounts and h...
CONL sinks 67% year to date as COIN slides 33%, underscoring the volatility tax embedded in daily-reset leveraged ETF...
When a senior vice president sells stock, it can spark questions about a company's direction. This guide explains wha...